...We Welcome You To The Resverlogix HUB In The AGORACOM COMMUNITY!

** Apabetalone (RVX-208) Currently Being Tested in a Phase 3 BETonMACE Cardiovascular Outcomes Trial ** Trial is Fully Enrolled and Top-Line Results Expected Q1 2019

Free
Message: Resverlogix Repays $68.8 Million Loan

... my bad!... no harm intended tada... I'm ecstatic this has come to pass, lost track of my numbers... thanks my friend...  kelsee 

Share
New Message
Please login to post a reply